• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Certara creates global strategic modeling and simulation consultancy

Certara creates global strategic modeling and simulation consultancy

July 8, 2015
CenterWatch Staff

Certara, a global biosimulation technology-enabled drug development company, has merged its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, Calif.

This move further strengthens Certara’s position in the burgeoning modeling and simulation/pharmacometric services field, broadening its modeling capabilities, deepening its therapeutic areas of experience and adding new value-added services and clinical outcomes databases. The resulting organization is called Certara Strategic Consulting.

“Certara now offers the broadest array of modeling, simulation and strategic pharmacometric services, from preclinical drug development through post-market approval,” said Edmundo Muniz, M.D., Ph.D., Certara CEO.

Certara Strategic Consulting has a strong presence in the U.S., Canada and Europe and early operations in Japan, Australia and China. Comprised of more than 70 scientists, consultants and industry professionals, Certara Strategic Consulting now can provide the most comprehensive range of outsourced modeling and simulation and strategic pharmacometric services to the global biopharma marketplace.

Certara Strategic Consulting currently serves more than 100 companies worldwide, including large pharmaceutical and established biotech companies, as well as medium and emerging biopharma companies, together with leading nonprofit foundations and regulatory agencies.

This transaction increases Certara’s scientific strength. It broadens the company’s modeling capabilities by adding model-based meta-analysis (MBMA), which uses highly-curated clinical trial data and parametric pharmacology models to increase drug development productivity, quantitatively inform portfolio management, and improve clinical trial success. A unique asset is the clinical outcomes databases for analyzing the comparative effectiveness of a new drug within its competitive landscape. These new offerings enhance Certara’s existing pharmacokinetic/pharmacodynamic (PK/PD) and physiologically-based pharmacokinetic (PBPK) modeling, clinical trial simulation and regulatory writing services.

The merger also deepens Certara’s therapeutic and special population areas of expertise, which include oncology, cardiovascular, orphan/rare diseases, central nervous system, pediatrics, immunology, infectious disease, metabolic and endocrine disease, women’s health, pain, respiratory and ophthalmology.

Certara has four business units: Certara Strategic Consulting, Certara Software, Simcyp (which focuses on PBPK) and Synchrogenix (which specializes in regulatory writing).

Financial details about the transaction have not been disclosed. 

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing